Table 3. CHESS PAEDs demographics.
| Characteristic | N = 691 |
|---|---|
| Age, y, mean (SD) | 10.33 (4.70) |
| Age category, y, n (%) | |
| < 2 | 20 (2.9) |
| 2–11 | 352 (50.9) |
| 12–17 | 319 (46.2) |
| Treatment approach, n (%) | |
| Prophylaxis | 468 (67.7) |
| EHL FVIII | 81 (17.3) |
| SHL or plasma-derived FVIII | 383 (81.8) |
| Unknown | 4 (0.9) |
| Other | 223 (32.3) |
| EHL FVIII | 27 (12.1) |
| SHL or plasma-derived FVIII | 109 (48.9) |
| No FVIII administered in prior 12 mo a | 83 (37.2) |
| Unknown | 4 (1.8) |
| Severity, n (%) | |
| Moderate | 287 (40.8) |
| Severe | 416 (59.2) |
| Country, n (%) | |
| France | 148 (21.1) |
| Germany | 112 (15.9) |
| Italy | 167 (23.8) |
| Spain | 168 (23.9) |
| UK | 108 (15.4) |
Abbreviations: EHL, extended half-life; SD, standard deviation; SHL, standard half-life.
a
All participants who had not received FVIII in the prior 12 months had moderate hemophilia A.